Immatics (IMTX) Equity Average (2021 - 2025)
Immatics' (IMTX) quarterly Equity Average came in at $987.0 million in Q4 2025, up 91.52% year-on-year from $515.3 million in Q4 2024, and up 94.87% quarter-over-quarter from $506.5 million in Q3 2025.
Immatics (IMTX) Equity Average (2021 - 2025) Analysis & Trends
Immatics has disclosed Equity Average across 5 years of filings, most recently posting $987.0 million for Q4 2025.
- Equity Average for Q4 2025 came in at $987.0 million, up 91.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $987.0 million (up 91.52% YoY), and the FY2025 annual result was $1.0 billion, up 142.5% from the prior year.
- Equity Average came in at $987.0 million for Q4 2025 at Immatics, up from $506.5 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $987.0 million in Q4 2025 to a low of $34.5 million in Q4 2021.
- The 5-year median for Equity Average is $252.8 million (2023), against an average of $314.0 million.
- Peak annual rise in Equity Average reached 365.92% in 2022, while the deepest fall reached 78.5% in 2022.
- Immatics' Equity Average stood at $34.5 million in 2021, then jumped by 365.92% to $160.7 million in 2022, then surged by 56.74% to $251.9 million in 2023, then soared by 104.56% to $515.3 million in 2024, then jumped by 91.52% to $987.0 million in 2025.
- The last three Equity Average figures came in at $987.0 million (Q4 2025), $506.5 million (Q3 2025), and $545.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 987.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 987.00 Mn |
| Sep 30, 2025 | 506.50 Mn |
| Jun 30, 2025 | 545.16 Mn |
| Mar 31, 2025 | 589.36 Mn |
| Dec 31, 2024 | 515.34 Mn |
| Sep 30, 2024 | 413.49 Mn |
| Jun 30, 2024 | 419.38 Mn |
| Mar 31, 2024 | 331.16 Mn |
| Dec 31, 2023 | 251.92 Mn |
| Sep 30, 2023 | 253.66 Mn |
| Jun 30, 2023 | 226.19 Mn |
| Mar 31, 2023 | 211.11 Mn |
| Dec 31, 2022 | 160.72 Mn |
| Sep 30, 2022 | 123.65 Mn |
| Jun 30, 2022 | 131.75 Mn |
| Mar 31, 2022 | 78.85 Mn |
| Dec 31, 2021 | 34.50 Mn |
| Sep 30, 2021 | 54.23 Mn |
| Jun 30, 2021 | 79.10 Mn |
| Mar 31, 2021 | 366.74 Mn |